Renal Resistance Could Improve Organ Evaluation
FORT LAUDERDALE, Fla.—Renal resistance after three hours of machine perfusion may be a more sensitive marker than renal histology for predicting allograft survival, researchers reported.
FORT LAUDERDALE, Fla.—Renal resistance after three hours of machine perfusion may be a more sensitive marker than renal histology for predicting allograft survival, researchers reported.
Angiographic kidney embolization before allograft nephrectomy reduced blood loss, cut operating time.
Fungal infections, especially invasive candidiasis and invasive aspergillosis, remain problematic among solid organ transplant recipients (SOT), but overall mortality appears to have improved, new findings confirm.
Clinical stage is the only preoperative variable independently associated with positive surgical margins (PSMs) following robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer, according to researchers.
Mission Pharmacal Company has introduced the Urocit-K 15 mEq (potassium citrate) extended-release tablet.
Vantia Therapeutics, a British pharmaceutical company, has begun a Phase 2b trial of its lead development compound VA106483 for nocturia, according to a company statement.
Victoza (liraglutide [rDNA origin] injection) is now available in the United States, according to the product’s maker, Novo Nordisk.
The FDA has approved a risk management program to inform health care providers and their patients about the risks of erythropoiesis-stimulating agents (ESAs), which include epoetin alfa and darbepoetin alfa.
The FDA has approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and children aged six weeks through five years.
The FDA approved the use of Benicar (olmesartan medoxomil) for the treatment of hypertension in individuals aged 6 to 16 years. The drug original was cleared in 2002 for the treatment of adult hypertension.